Implantable Infusion Pumps Market Analysis & Trends- Application (Cancer Treatment, Cancer Pain, Noncancer Pain, Spasticity, Analgesia, Mixed Sarcoma and Skin Cancers, Gastric Cancer and Diabetes Mellitus) - Forecast to 2025

  • ID: 3951938
  • Report
  • 159 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Codman & Shurtleff
  • Debiotech S.A.
  • Delpor, Inc.
  • Eli Lilly and Company
  • Flowonix Medical, Inc.
  • FluidSynchrony, LLC
  • MORE
The Global Implantable Infusion Pumps Market is poised to grow at a CAGR of around 6.3% over the next decade to reach approximately $14.33 billion by 2025. Some of the prominent trends that the market is Chemotherapy for cancer patients, Surge for near-physiologic programmable method of insulin delivery, Increase in device based drug delivery technologies and Growth Opportunities/Investment Opportunities.

Based on Application the market is categorized into Cancer Treatment, Spasticity, Analgesia and Diabetes Mellitus. The Cancer Treatment segment is further divided as Cancer Pain, Noncancer Pain, Mixed Sarcoma and Skin Cancers and Gastric Cancer.

This industry report analyzes the global markets for Implantable Infusion Pumps across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Implantable Infusion Pumps Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- Africa
- Caribbean

Report Highlights:

- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Codman & Shurtleff
  • Debiotech S.A.
  • Delpor, Inc.
  • Eli Lilly and Company
  • Flowonix Medical, Inc.
  • FluidSynchrony, LLC
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Application Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Chemotherapy for cancer patients
3.1.2 Surge for near-physiologic programmable method of insulin delivery
3.1.3 Increase in device based drug delivery technologies
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Implantable Infusion Pumps Market, By Application
4.1 Cancer Treatment
4.1.1 Cancer Treatment Market Forecast to 2025 (US$ MN)
4.1.1.1 Cancer Pain
4.1.1.1.1 Cancer Pain Market Forecast to 2025 (US$ MN)
4.1.1.2 Noncancer Pain
4.1.1.2.1 Noncancer Pain Market Forecast to 2025 (US$ MN)
4.1.1.3 Mixed Sarcoma and Skin Cancers
4.1.1.3.1 Mixed Sarcoma and Skin Cancers Market Forecast to 2025 (US$ MN)
4.1.1.4 Gastric Cancer
4.1.1.4.1 Gastric Cancer Market Forecast to 2025 (US$ MN)
4.2 Spasticity
4.2.1 Spasticity Market Forecast to 2025 (US$ MN)
4.3 Analgesia
4.3.1 Analgesia Market Forecast to 2025 (US$ MN)
4.4 Diabetes Mellitus
4.4.1 Diabetes Mellitus Market Forecast to 2025 (US$ MN)

5 Implantable Infusion Pumps Market, By Geography
5.1 North America
5.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
5.1.1.1 US
5.1.1.2 Canada
5.1.1.3 Mexico
5.2 Europe
5.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
5.2.1.1 France
5.2.1.2 Germany
5.2.1.3 Italy
5.2.1.4 Spain
5.2.1.5 UK
5.2.1.6 Rest of Europe
5.3 Asia Pacific
5.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
5.3.1.1 China
5.3.1.2 Japan
5.3.1.3 India
5.3.1.4 Australia
5.3.1.5 New Zealand
5.3.1.6 Rest of Asia Pacific
5.4 Middle East
5.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
5.4.1.1 Saudi Arabia
5.4.1.2 UAE
5.4.1.3 Rest of Middle East
5.5 Latin America
5.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
5.5.1.1 Argentina
5.5.1.2 Brazil
5.5.1.3 Rest of Latin America
5.6 Rest of the World (RoW)
5.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
5.6.1.1 Africa
5.6.1.2 Caribbean

6 Key Player Activities
6.1 Acquisitions & Mergers
6.2 Agreements, Partnerships, Collaborations and Joint Ventures
6.3 Product Launch & Expansions
6.4 Other Activities

7 Leading Companies
7.1 Alnylam Pharmaceuticals, Inc.
7.2 Debiotech S.A.
7.3 Delpor, Inc.
7.4 Eksigent Technologies, LLC
7.5 Eli Lilly and Company
7.6 Flowonix Medical, Inc.
7.7 FluidSynchrony, LLC
7.8 Intarcia Therapeutics, Inc.
7.9 Medallion Therapeutics, Inc.
7.10 Nano Precision Medical
7.11 Pharmaco-Kinesis Corporation
7.12 University of Southern California Company
7.13 Halyard Health
7.14 Codman & Shurtleff

List of Tables

Table 1 Global Implantable Infusion Pumps Market By Region, Market Forecast (2013-2025) (US $MN)
Table 2 Global Implantable Infusion Pumps Market By Application, Market Forecast (2013-2025) (US $MN)
Table 3 Global Implantable Infusion Pumps Market By Cancer Treatment, Market Forecast (2013-2025) (US $MN)
Table 4 Global Implantable Infusion Pumps Market By Cancer Pain, Market Forecast (2013-2025) (US $MN)
Table 5 Global Implantable Infusion Pumps Market By Noncancer Pain, Market Forecast (2013-2025) (US $MN)
Table 6 Global Implantable Infusion Pumps Market By Mixed Sarcoma and Skin Cancers, Market Forecast (2013-2025) (US $MN)
Table 7 Global Implantable Infusion Pumps Market By Gastric Cancer, Market Forecast (2013-2025) (US $MN)
Table 8 Global Implantable Infusion Pumps Market By Spasticity, Market Forecast (2013-2025) (US $MN)
Table 9 Global Implantable Infusion Pumps Market By Analgesia, Market Forecast (2013-2025) (US $MN)
Table 10 Global Implantable Infusion Pumps Market By Diabetes Mellitus, Market Forecast (2013-2025) (US $MN)
Table 11 North America Implantable Infusion Pumps Market By Country, Market Forecast (2013-2025) (US $MN)
Table 12 North America Implantable Infusion Pumps Market By Application, Market Forecast (2013-2025) (US $MN)
Table 13 North America Implantable Infusion Pumps Market By Cancer Treatment, Market Forecast (2013-2025) (US $MN)
Table 14 North America Implantable Infusion Pumps Market By Cancer Pain, Market Forecast (2013-2025) (US $MN)
Table 15 North America Implantable Infusion Pumps Market By Noncancer Pain, Market Forecast (2013-2025) (US $MN)
Table 16 North America Implantable Infusion Pumps Market By Mixed Sarcoma and Skin Cancers, Market Forecast (2013-2025) (US $MN)
Table 17 North America Implantable Infusion Pumps Market By Gastric Cancer, Market Forecast (2013-2025) (US $MN)
Table 18 North America Implantable Infusion Pumps Market By Spasticity, Market Forecast (2013-2025) (US $MN)
Table 19 North America Implantable Infusion Pumps Market By Analgesia, Market Forecast (2013-2025) (US $MN)
Table 20 North America Implantable Infusion Pumps Market By Diabetes Mellitus, Market Forecast (2013-2025) (US $MN)
Table 21 Europe Implantable Infusion Pumps Market By Country, Market Forecast (2013-2025) (US $MN)
Table 22 Europe Implantable Infusion Pumps Market By Application, Market Forecast (2013-2025) (US $MN)
Table 23 Europe Implantable Infusion Pumps Market By Cancer Treatment, Market Forecast (2013-2025) (US $MN)
Table 24 Europe Implantable Infusion Pumps Market By Cancer Pain, Market Forecast (2013-2025) (US $MN)
Table 25 Europe Implantable Infusion Pumps Market By Noncancer Pain, Market Forecast (2013-2025) (US $MN)
Table 26 Europe Implantable Infusion Pumps Market By Mixed Sarcoma and Skin Cancers, Market Forecast (2013-2025) (US $MN)
Table 27 Europe Implantable Infusion Pumps Market By Gastric Cancer, Market Forecast (2013-2025) (US $MN)
Table 28 Europe Implantable Infusion Pumps Market By Spasticity, Market Forecast (2013-2025) (US $MN)
Table 29 Europe Implantable Infusion Pumps Market By Analgesia, Market Forecast (2013-2025) (US $MN)
Table 30 Europe Implantable Infusion Pumps Market By Diabetes Mellitus, Market Forecast (2013-2025) (US $MN)
Table 31 Asia Pacific Implantable Infusion Pumps Market By Country, Market Forecast (2013-2025) (US $MN)
Table 32 Asia Pacific Implantable Infusion Pumps Market By Application, Market Forecast (2013-2025) (US $MN)
Table 33 Asia Pacific Implantable Infusion Pumps Market By Cancer Treatment, Market Forecast (2013-2025) (US $MN)
Table 34 Asia Pacific Implantable Infusion Pumps Market By Cancer Pain, Market Forecast (2013-2025) (US $MN)
Table 35 Asia Pacific Implantable Infusion Pumps Market By Noncancer Pain, Market Forecast (2013-2025) (US $MN)
Table 36 Asia Pacific Implantable Infusion Pumps Market By Mixed Sarcoma and Skin Cancers, Market Forecast (2013-2025) (US $MN)
Table 37 Asia Pacific Implantable Infusion Pumps Market By Gastric Cancer, Market Forecast (2013-2025) (US $MN)
Table 38 Asia Pacific Implantable Infusion Pumps Market By Spasticity, Market Forecast (2013-2025) (US $MN)
Table 39 Asia Pacific Implantable Infusion Pumps Market By Analgesia, Market Forecast (2013-2025) (US $MN)
Table 40 Asia Pacific Implantable Infusion Pumps Market By Diabetes Mellitus, Market Forecast (2013-2025) (US $MN)
Table 41 Middle East Implantable Infusion Pumps Market By Country, Market Forecast (2013-2025) (US $MN)
Table 42 Middle East Implantable Infusion Pumps Market By Application, Market Forecast (2013-2025) (US $MN)
Table 43 Middle East Implantable Infusion Pumps Market By Cancer Treatment, Market Forecast (2013-2025) (US $MN)
Table 44 Middle East Implantable Infusion Pumps Market By Cancer Pain, Market Forecast (2013-2025) (US $MN)
Table 45 Middle East Implantable Infusion Pumps Market By Noncancer Pain, Market Forecast (2013-2025) (US $MN)
Table 46 Middle East Implantable Infusion Pumps Market By Mixed Sarcoma and Skin Cancers, Market Forecast (2013-2025) (US $MN)
Table 47 Middle East Implantable Infusion Pumps Market By Gastric Cancer, Market Forecast (2013-2025) (US $MN)
Table 48 Middle East Implantable Infusion Pumps Market By Spasticity, Market Forecast (2013-2025) (US $MN)
Table 49 Middle East Implantable Infusion Pumps Market By Analgesia, Market Forecast (2013-2025) (US $MN)
Table 50 Middle East Implantable Infusion Pumps Market By Diabetes Mellitus, Market Forecast (2013-2025) (US $MN)
Table 51 Latin America Implantable Infusion Pumps Market By Country, Market Forecast (2013-2025) (US $MN)
Table 52 Latin America Implantable Infusion Pumps Market By Application, Market Forecast (2013-2025) (US $MN)
Table 53 Latin America Implantable Infusion Pumps Market By Cancer Treatment, Market Forecast (2013-2025) (US $MN)
Table 54 Latin America Implantable Infusion Pumps Market By Cancer Pain, Market Forecast (2013-2025) (US $MN)
Table 55 Latin America Implantable Infusion Pumps Market By Noncancer Pain, Market Forecast (2013-2025) (US $MN)
Table 56 Latin America Implantable Infusion Pumps Market By Mixed Sarcoma and Skin Cancers, Market Forecast (2013-2025) (US $MN)
Table 57 Latin America Implantable Infusion Pumps Market By Gastric Cancer, Market Forecast (2013-2025) (US $MN)
Table 58 Latin America Implantable Infusion Pumps Market By Spasticity, Market Forecast (2013-2025) (US $MN)
Table 59 Latin America Implantable Infusion Pumps Market By Analgesia, Market Forecast (2013-2025) (US $MN)
Table 60 Latin America Implantable Infusion Pumps Market By Diabetes Mellitus, Market Forecast (2013-2025) (US $MN)
Table 61 RoW Implantable Infusion Pumps Market By Country, Market Forecast (2013-2025) (US $MN)
Table 62 RoW Implantable Infusion Pumps Market By Application, Market Forecast (2013-2025) (US $MN)
Table 63 RoW Implantable Infusion Pumps Market By Cancer Treatment, Market Forecast (2013-2025) (US $MN)
Table 64 RoW Implantable Infusion Pumps Market By Cancer Pain, Market Forecast (2013-2025) (US $MN)
Table 65 RoW Implantable Infusion Pumps Market By Noncancer Pain, Market Forecast (2013-2025) (US $MN)
Table 66 RoW Implantable Infusion Pumps Market By Mixed Sarcoma and Skin Cancers, Market Forecast (2013-2025) (US $MN)
Table 67 RoW Implantable Infusion Pumps Market By Gastric Cancer, Market Forecast (2013-2025) (US $MN)
Table 68 RoW Implantable Infusion Pumps Market By Spasticity, Market Forecast (2013-2025) (US $MN)
Table 69 RoW Implantable Infusion Pumps Market By Analgesia, Market Forecast (2013-2025) (US $MN)
Table 70 RoW Implantable Infusion Pumps Market By Diabetes Mellitus, Market Forecast (2013-2025) (US $MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Alnylam Pharmaceuticals, Inc.
- Codman & Shurtleff
- Debiotech S.A.
- Delpor, Inc.
- Eksigent Technologies, LLC
- Eli Lilly and Company
- Flowonix Medical, Inc.
- FluidSynchrony, LLC
- Halyard Health
- Intarcia Therapeutics, Inc.
- Medallion Therapeutics, Inc.
- Nano Precision Medical
- Pharmaco-Kinesis Corporation
- University of Southern California Company
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll